These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antibiotic use among twelve Canadian First Nations communities: a retrospective chart review of skin and soft tissue infections. Jeong D; Nguyen HNT; Tyndall M; Schreiber YS BMC Infect Dis; 2020 Feb; 20(1):118. PubMed ID: 32041554 [TBL] [Abstract][Full Text] [Related]
23. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598 [TBL] [Abstract][Full Text] [Related]
24. Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era. Mistry RD; Weisz K; Scott HF; Alpern ER Acad Emerg Med; 2010 Feb; 17(2):187-93. PubMed ID: 20370748 [TBL] [Abstract][Full Text] [Related]
25. Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections. Frei CR; Miller ML; Lewis JS; Lawson KA; Hunter JM; Oramasionwu CU; Talbert RL J Am Board Fam Med; 2010; 23(6):714-9. PubMed ID: 21057066 [TBL] [Abstract][Full Text] [Related]
26. Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health Centers. Piper Jenks N; Pardos de la Gandara M; D'Orazio BM; Correa da Rosa J; Kost RG; Khalida C; Vasquez KS; Coffran C; Pastagia M; Evering TH; Parola C; Urban T; Salvato S; Barsanti F; Coller BS; Tobin JN Travel Med Infect Dis; 2016; 14(6):551-560. PubMed ID: 27773780 [TBL] [Abstract][Full Text] [Related]
27. Clinical management of skin and soft tissue infections in the U.S. Emergency Departments. Mistry RD; Shapiro DJ; Goyal MK; Zaoutis TE; Gerber JS; Liu C; Hersh AL West J Emerg Med; 2014 Jul; 15(4):491-8. PubMed ID: 25035757 [TBL] [Abstract][Full Text] [Related]
28. Treatment options for uncomplicated community-acquired skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: oral antimicrobial agents. Zervos M Surg Infect (Larchmt); 2008; 9 Suppl 1():s29-34. PubMed ID: 18844472 [TBL] [Abstract][Full Text] [Related]
29. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Ruhe JJ; Smith N; Bradsher RW; Menon A Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447 [TBL] [Abstract][Full Text] [Related]
30. Staphylococcus aureus skin and soft tissue infections: can we anticipate the culture result? Bar-Meir M; Tan TQ Clin Pediatr (Phila); 2010 May; 49(5):432-8. PubMed ID: 20118096 [TBL] [Abstract][Full Text] [Related]
32. Update: Community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infection surveillance among active duty military personnel at Fort Benning GA, 2008-2010. Leamer NK; Clemmons NS; Jordan NN; Pacha LA Mil Med; 2013 Aug; 178(8):914-20. PubMed ID: 23929055 [TBL] [Abstract][Full Text] [Related]
33. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus. Ray GT; Suaya JA; Baxter R Diagn Microbiol Infect Dis; 2013 May; 76(1):24-30. PubMed ID: 23537783 [TBL] [Abstract][Full Text] [Related]
34. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains isolated from outpatients with skin and soft tissue infections in Wuhan, China. Liu X; Liang J; Jiang Y; Wang B; Yuan H; Zhang L; Zhou Y; Xu H; Zhou W Pathog Dis; 2016 Jun; 74(4):ftw026. PubMed ID: 27060098 [TBL] [Abstract][Full Text] [Related]
35. Board-certified emergency physicians' treatment of skin and soft tissue infections in the community-acquired methicillin-resistant Staphylococcus aureus era. LoVecchio F; Perera N; Casanova L; Mulrow M; Pohl A Am J Emerg Med; 2009 Jan; 27(1):68-70. PubMed ID: 19041536 [TBL] [Abstract][Full Text] [Related]
36. Increase in the prevalence of Panton-Valentine leukocidin and clonal shift in community-onset methicillin-resistant Staphylococcus aureus causing skin and soft-tissue infections in the Rhine-Neckar Region, Germany, 2012-2016. Klein S; Menz MD; Zanger P; Heeg K; Nurjadi D Int J Antimicrob Agents; 2019 Mar; 53(3):261-267. PubMed ID: 30412736 [TBL] [Abstract][Full Text] [Related]
37. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. Daum RS; Miller LG; Immergluck L; Fritz S; Creech CB; Young D; Kumar N; Downing M; Pettibone S; Hoagland R; Eells SJ; Boyle MG; Parker TC; Chambers HF; N Engl J Med; 2017 Jun; 376(26):2545-2555. PubMed ID: 28657870 [TBL] [Abstract][Full Text] [Related]
38. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups. Changchien CH; Chen SW; Chen YY; Chu C BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530 [TBL] [Abstract][Full Text] [Related]
39. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Talan DA; Krishnadasan A; Gorwitz RJ; Fosheim GE; Limbago B; Albrecht V; Moran GJ; Clin Infect Dis; 2011 Jul; 53(2):144-9. PubMed ID: 21690621 [TBL] [Abstract][Full Text] [Related]
40. In vitro activity of tedizolid and other comparator drugs in methicillin-resistant Staphylococcus aureus isolates in skin and soft tissue infections in seven Colombian hospitals. Leal AL; Ovalle MV; Cortés JA; Montañes AM; De la Rosa ZR; Rodríguez JY; Gualtero S; Ariza B; Sussman O; Torres MDP Biomedica; 2018 Dec; 38(4):507-513. PubMed ID: 30653864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]